Viral Replication Enzymes and their Inhibitors Part B

1st Edition, Volume 50 - November 25, 2021
Editors: Craig E. Cameron, Jamie J. Arnold
Language: English
Hardback ISBN:
9 7 8 - 0 - 3 2 3 - 9 0 0 1 6 - 4
eBook ISBN:
9 7 8 - 0 - 3 2 3 - 9 0 0 1 7 - 1

Viral Replication Enzymes and their Inhibitors, Part B, Volume 50 in The Enzymes series, highlights new advances in the field, with this new volume presenting interesting chapte… Read more

Purchase options

Institutional subscription on ScienceDirect

Request a sales quote

Viral Replication Enzymes and their Inhibitors, Part B, Volume 50 in The Enzymes series, highlights new advances in the field, with this new volume presenting interesting chapters on a variety of topics surrounding enzymes.

Cover image
Title page
Table of Contents
Copyright
Contributors
Preface
Chapter One: Structure and function of the poxvirus transcription machinery
Abstract
1: Introduction
2: Structure of the poxviral core polymerase and its relation to nuclear polymerases
3: The elongation complex
4: The complete vaccinia RNA polymerase
5: Perspectives of poxvirus structural biology
Chapter Two: Structure and function of negative-strand RNA virus polymerase complexes
Abstract
1: Introduction
2: Architecture of the negative-strand RNA virus replication machinery
3: Polymerase domains and functions
4: Models of RNA synthesis
5: Conclusions and perspectives
Chapter Three: DNA polymerases of herpesviruses and their inhibitors
Abstract
1: Introduction
2: Herpesvirus DNA polymerases
3: Antiviral agents targeting herpesvirus DNA polymerases
4: Resistance of herpesviruses to DNA polymerase inhibitors
5: Conclusions and perspectives
Acknowledgments
Chapter Four: Herpesvirus DNA polymerase: Structures, functions, and mechanisms
Abstract
1: Introduction
2: Overview of mechanisms of genome replication during productive infection
3: HSV DNA polymerase—The first quarter century
4: Structures of herpesvirus polymerase subunits and the holoenzyme
5: Activities of Pol
6: Activities of UL42
7: Replication fidelity (or lack thereof)
8: Approaches to new antiviral DNA polymerase inhibitors
9: Conclusions and perspectives including unanswered questions
Acknowledgments
Chapter Five: Retroviral reverse transcriptase: Structure, function and inhibition
Abstract
1: Discovery of reverse transcriptase
2: HIV reverse transcription
3: Structure of HIV RT
4: Mechanism of RT DNA polymerization
5: Mechanism of HIV RT RNase H
6: Nucleoside RT inhibitors (NRTIs)
7: Nonnucleoside RT inhibitors (NNRTIs)
8: Conclusions
Acknowledgments
Chapter Six: The hepatitis B virus polymerase
Abstract
1: HBV—The virus and disease
2: Viral replication cycle
3: Reverse transcription
4: Polymerase gene structure, genetics, and expression
5: pgRNA binding, encapsidation, and enzymatic activation
6: DNA priming
7: Role of P in strand transfer reactions
8: Reverse transcriptase and DNA polymerase activities
9: Ribonuclease H activity
10: Roles of P in addition to genomic replication
11: P as a drug target
12: Comparison to retroviral reverse transcriptases
13: Perspectives
Acknowledgments
Chapter Seven: Retroviral RNase H: Structure, mechanism, and inhibition
Abstract
1: Introduction
2: RNH function in retrovirus
3: RNH inhibition
4: Summary
Chapter Eight: Retroviral integrase: Structure, mechanism, and inhibition
Abstract
1: Introduction
2: Enzymatic functions of retroviral IN
3: Structures of individual IN domains
4: IN multimerization
5: Structures of multi-domain IN constructs
6: Structures of nucleoprotein intasome assemblies
7: Molecular mechanism of retroviral integration
8: Chromatin engagement by a retroviral intasome
9: The role of host factors in the enzymatic activity of IN
10: Non-catalytic functions of retroviral IN
11: Catalytic inhibition of integration
12: Clinically approved INSTIs for use in antiretroviral therapy
13: Developmental INSTIs containing the naphthyridine core scaffold
14: Viral resistance against clinically used INSTIs
15: Future directions with INSTI development
16: Allosteric integrase inhibitors
17: Concluding remarks
Acknowledgments
Chapter Nine: Viral proteases: Structure, mechanism and inhibition
Abstract
1: Introduction
2: Viral proteases targeted with antiviral drugs
3: Viral proteases as emerging therapeutic targets
4: Conclusion
Acknowledgments
Chapter Ten: RNA helicases required for viral propagation in humans
Abstract
1: Introduction
2: Hepatitis C virus NS3 helicase
3: Coronaviruses, SARS CoV-1 and SARS CoV-2 NSP13 helicases
4: DEAD-Box RNA helicases in viral multiplication not encoded in the viral genome
Chapter Eleven: Viral genome packaging machines: Structure and enzymology
Abstract
1: Introduction
2: The terminase enzymes
3: The lambda system
4: Initiation of genome packaging
5: The genome packaging complex
6: The translocating motor
7: Termination of packaging
8: Conclusion

Life Sciences

Physical Sciences & Engineering

Social Sciences & Humanities

Health

Viral Replication Enzymes and their Inhibitors Part B

Purchase options

Institutional subscription on ScienceDirect

Craig E. Cameron

Jamie J. Arnold